cerrar
Tagged with Opinion

A ‘Bold Vision’ of CAR-T Patient Engagement
Marc Boutin, Novartis’ global head of patient engagement, outlines the company’s “bold vision” of patient engagement and the actions that need…

Agility, Responsiveness, & Resilience: Five Takeaways from…
Walt Vernon is CEO of US-based healthcare facilities consulting firm, Mazzetti, and non-profit, Sextant. He is on the Board of the FGI and served on…

Pharma Manufacturing in Africa: An Opportunity to Strengthen…
Medicines for Africa's Lenias Hwenda highlights the vast gaps in COVID-19 vaccine access globally, especially in Africa where just six percent of the…

COP26 & Building a Healthier, Collaborative, Interconnected…
The research evidence is unequivocal, public, planetary and economic health are inextricably linked and no continent, country or community is immune…

100 Years of Insulin: An Access to Medicines Issue Writ Large
On the 100th anniversary of the development of insulin, regular PharmaBoardroom contributor Brendan Shaw* examines the shocking global disparities in…

Aligning Stakeholder Partnerships in Latin America: Best…
Writing in the November issue of DIA Global Forum, Lawrence Liberti, Mario Alanis, Pravin Chopra, and Silvia Bendiner examine how the COVID-19…

Australia Aiming Targeted Therapies Toward Truly Personalised…
In conversation in the November issue of DIA’s Global Forum magazine, Australian Pharmaceutical medical and scientific Professionals Association…

Sustainability & Pharma Procurement in Europe: Are You…
In the wake of the 2021 United Nations Climate Change Conference (COP26), sustainability is once more a hot-button issue across all industries,…

Efficiency Isn’t Enough – Healthcare Needs Resilience
Cyril Titeux, senior VP mid-sized markets EMEA & strategic leader at Janssen, argues that the current focus of many health systems on efficiency,…

The Pharma Commercialisation Model of the Future
Amgen MEA’s Mohamed Nasser* examines the current pharma commercialisation model, posits how the entire healthcare ecosystem’s rapid and effective…

2021 Drug Formulary Exclusions Continue to Reduce Therapy Choice…
Susan L. Lang outlines how pharma companies can navigate drug formulary exclusions, numbers of which have been rising in recent years, and ensure that…

CADTH CEO Suzanne McGurn on the Key Challenges in HTA Today
In conversation in the October edition of DIA’s Global Forum magazine, Canadian Agency for Drugs and Technologies in Health (CADTH) CEO Suzanne…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here